MedPath

四川大冢制药有限公司

Ownership
-
Established
2002-08-13
Employees
-
Market Cap
-
Website
https://www.scotsuka.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

72

NMPA:72

Drug Approvals

Oryzanol Tablets

Product Name
谷维素片
Approval Number
国药准字H51020130
Approval Date
Jun 14, 2024
NMPA

Procaterol Hydrochloride Oral Solution

Product Name
盐酸丙卡特罗口服溶液
Approval Number
国药准字H20093290
Approval Date
May 30, 2023
NMPA

Aripiprazole Oral Solution

Product Name
阿立哌唑口服溶液
Approval Number
国药准字H20223529
Approval Date
Jul 19, 2022
NMPA

Ambroxol Hydrochloride Oral Solution

Product Name
盐酸氨溴索口服溶液
Approval Number
国药准字H20153066
Approval Date
Mar 21, 2022
NMPA

Ambroxol Hydrochloride Oral Solution

Product Name
盐酸氨溴索口服溶液
Approval Number
国药准字H20073944
Approval Date
Mar 21, 2022
NMPA

玉屏风口服液

Approval Number
国药准字Z51020057
Approval Date
Jan 12, 2022
NMPA

脑心舒口服液

Approval Number
国药准字Z51020055
Approval Date
Jan 12, 2022
NMPA

乙肝扶正胶囊

Approval Number
国药准字Z51022054
Approval Date
May 14, 2021
NMPA

乙肝解毒胶囊

Approval Number
国药准字Z51022055
Approval Date
May 14, 2021
NMPA

Montelukast Sodium Chewable Tablets

Product Name
孟鲁司特钠咀嚼片
Approval Number
国药准字H20064828
Approval Date
Jul 21, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.